Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bourut

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancer Letters|June 1, 1985
Antitumor activity of l-OHP in miceG Mathé, Y Kidani, M Noji, et al.
Cancer Research|June 1, 1984
A four-day subrenal capsule assay for testing the effectiveness of anticancer drugs against human tumorsF A Levi, J P Blum, G Lemaigre, et al.
Anti-Cancer Drug Design|June 1, 1988
On a new class of mixed-function drugs associating nitroimidazoles and CENU: the NICE-NUA Carminati, J L Barascut, E Chenut, et al.
Clinical Endocrinology|September 6, 2000
A new missense mutation in the calcium-sensing receptor in familial benign hypercalcaemia associated with partial lipoatrophy and insulin resistant diabetesC Vigouroux, C Bourut, B Guerci, et al.
British Journal of Pharmacology|November 1, 1986
Cytostatic action of two nitrosoureas derived from cysteamineC Bourut, E Chenu, D Godenèche, et al.
Cancer Letters|December 1, 1984
Experimental protection by a luteinizing hormone-releasing hormone agonist of a bone marrow nitrosourea aplasia. Preliminary observationsG Lemaigre, R Maral, C Bourut, et al.
Oncology|January 1, 1985
Comparison of the experimental antitumor activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free stateR Maral, C Bourut, E Chenu, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 1997
Genetic exclusion of 14 candidate genes in lipoatropic diabetes using linkage analysis in 10 consanguineous familiesC Vigouroux, E Khallouf, C Bourut, et al.
Diabetes|November 15, 2000
Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophyC Vigouroux, J Magré, M C Vantyghem, et al.
Nature Genetics|August 2, 2001
Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13J Magré, M Delépine, E Khallouf, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Letters|June 1, 1985
Antitumor activity of l-OHP in miceG Mathé, Y Kidani, M Noji, et al.
Cancer Research|June 1, 1984
A four-day subrenal capsule assay for testing the effectiveness of anticancer drugs against human tumorsF A Levi, J P Blum, G Lemaigre, et al.
Anti-Cancer Drug Design|June 1, 1988
On a new class of mixed-function drugs associating nitroimidazoles and CENU: the NICE-NUA Carminati, J L Barascut, E Chenut, et al.
Clinical Endocrinology|September 6, 2000
A new missense mutation in the calcium-sensing receptor in familial benign hypercalcaemia associated with partial lipoatrophy and insulin resistant diabetesC Vigouroux, C Bourut, B Guerci, et al.
British Journal of Pharmacology|November 1, 1986
Cytostatic action of two nitrosoureas derived from cysteamineC Bourut, E Chenu, D Godenèche, et al.
Cancer Letters|December 1, 1984
Experimental protection by a luteinizing hormone-releasing hormone agonist of a bone marrow nitrosourea aplasia. Preliminary observationsG Lemaigre, R Maral, C Bourut, et al.
Oncology|January 1, 1985
Comparison of the experimental antitumor activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free stateR Maral, C Bourut, E Chenu, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 1997
Genetic exclusion of 14 candidate genes in lipoatropic diabetes using linkage analysis in 10 consanguineous familiesC Vigouroux, E Khallouf, C Bourut, et al.
Diabetes|November 15, 2000
Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophyC Vigouroux, J Magré, M C Vantyghem, et al.
Nature Genetics|August 2, 2001
Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13J Magré, M Delépine, E Khallouf, et al.
Pageof 3